Corvus Pharmaceuticals, Inc. short interest in 2019
In 2019, Corvus Pharmaceuticals, Inc.'s disclosed short interest ran from 4.57% of shares outstanding on 15 Oct 2019 to 4.66% on 31 Dec 2019, a change of +0.09 percentage points. The year's high was 4.66% on 31 Dec 2019 and its low 4.57% on 15 Oct 2019, averaging 4.61% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.66 days on 31 Oct 2019. Full history: Corvus Pharmaceuticals, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2019 in figures
- Start of year
- 4.57% (15 Oct 2019)
- End of year
- 4.66% (31 Dec 2019)
- Change
- +0.09 pp
- High
- 4.66% (31 Dec 2019)
- Low
- 4.57% (15 Oct 2019)
- Average
- 4.61%
- Highest days to cover
- 13.66 (31 Oct 2019)
- SEC filings marked
- 8
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Oct 2019 | 4.57% | 12.05 | 10-K filed, results (8-K), 10-Q filed, results (8-K), 10-Q filed, results (8-K) |
| 31 Oct 2019 | 4.60% | 13.66 | 10-Q filed, results (8-K) |
| 15 Nov 2019 | 4.61% | 8.54 | |
| 29 Nov 2019 | 4.61% | 10.34 | |
| 13 Dec 2019 | 4.60% | 4.57 | |
| 31 Dec 2019 | 4.66% | 5.92 |
See also: Corvus Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.